Biologics

Michael Gordon, MD, a spine surgeon with Hoag Orthopedic Institute in Irvine, Calif., weighs in on trends he sees with regard to the use of spinal biologics.

Shelton, Conn.-based Spine Wave launched the GraftMag Graft Delivery System.

Surgeons have implanted 50 Bone Solutions' OsteoCrete.

Technavio analysts identified the top three trends of the global spinal biologics market between 2018 and 2022.

Cellular Biomedicine Group partnered with GE Healthcare to accelerate its stem cell therapy manufacturing timeline.

Former North American Spine Society President William Watters, MD, of Houston Medical, discusses the biggest spine technology, clinical and business trends for 2018.

The FDA granted clearance for Mayo Clinic Center for Regenerative Medicine in Jacksonville, Fla., to treat patients with its stem cell production platform, according to The Florida Times-Union.

The FDA cleared ORTHOReBIRTH USA's ReBOSSIS. ORTHOReBIRTH develops orthopedic biologics.

Kleiner Device Labs initiated a full commercial launch of its spinal bone graft delivery tool.

Sealantis, the Haifa, Israel-based developer of absorbable surgical sealants and adhesives, received CE marking approval for its Seal-G Surgical Sealant. The CE marking will allow the product to be marketed in Europe and other countries.